Over 47% of Critically Ill Oncology Patients Survive Non-Elective ICU Admission Despite High Mortality: 5-Year Study

While 17 to 20% of hematological and 7 to 10% of solid tumor patients require ICU support, a critical prognostic data gap remains in low- and middle-income countries. This prompted Dr. Surabhi Sandill, Dr. Seema Mishra, and colleagues from the All India Institute of Medical Sciences (AIIMS) in New Delhi to thoroughly analyze outcomes and identify specific mortality predictors for non-elective medical admissions of critically ill cancer patients.

Therefore, the 5-year retrospective study analyzed 204 adult patients with solid or hematological malignancies requiring unplanned medical ICU admission. Excluding post-operative cases, researchers used multivariate logistic regression to primarily evaluate ICU mortality and its clinical risk predictors, alongside secondary demographic and patient outcomes.

Key Clinical Findings of the Study Includes:

• Admission Drivers: Analysis found that leading catalysts for critical care admissions were febrile neutropenia (34.3%) and acute respiratory failure (31.8%), highlighting the severe physiological vulnerabilities of this highly immunocompromised population.

• Mortality Rate: Investigators reported an overall ICU mortality rate of 52.94%, with septic shock emerging as the predominant cause of death at 53.7%, followed by respiratory failure.

• Malignancy Impact: Researchers observed a notably higher mortality burden in patients battling hematological malignancies (53.92%) compared to those with solid organ tumors (44.12%), underscoring the severe complications intimately tied to blood cancers.

• Independent Predictors: Data demonstrated that invasive mechanical ventilation (IMV), vasopressor use, and hemodialysis exponentially increased mortality risks, with IMV showing a striking adjusted odds ratio of 15.98.

• Age Factor: The Study revealed that being under the age of 30 was a significant independent predictor of mortality, likely due to aggressive curative-intent regimens predisposing younger patients to severe cytopenia.

The results suggest that while critical illness in oncology presents severe physiological challenges, a substantial proportion of these patients possess a reasonable chance of surviving their intensive care stay, with their 52.94% in-ICU mortality heavily influenced by the severity of acute organ failure and the need for specific life-support interventions rather than the underlying cancer stage itself.

Implementing early clinical evaluations, ensuring timely transfers to intensive care settings, and adopting broadened admission criteria gently supported by objective diagnostic scoring systems could smoothly guide medical decision-making and subtly enhance overall patient survival.

As a retrospective single-center evaluation lacking standard admission scoring criteria or long-term quality of life metrics, these findings primarily serve to generate initial clinical hypotheses. This mildly invites the necessity for prospective, multicenter studies to gracefully further validate these prognostic indicators.

Reference

Sandill, S., Mishra, S., Garg, R., Gupta, N., Bharti, S. J., Kumar, V., Ratre, B., Vig, S., Pandit, A., Sagiraju, H. R., & Bhatnagar, S. (2026). Outcomes of Cancer Patients Requiring Non-elective Medical Admission to the Intensive Care Unit of a Tertiary Care Center in India: A 5-year Retrospective Study. Indian Journal of Critical Care Medicine, 30(1), 13–18.